Company News
Kilitch Drugs Divests Ethiopian Subsidiary for $14M
Kilitch Drugs announces divestment of entire stake in Ethiopian subsidiary Kilitch Estro Biotech PLC for $14 million to state-owned HarmeeCare Pharmaceuticals.
Proceeds will be used for debt reduction
